发明名称 Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds
摘要 A method of treating and/or inhibiting immunological disease states which are associated with a Th1 dominated reaction pattern of the pathological immune response by administering to a patient in need thereof an effective amount of at least one non-endogenous gestagen compound.
申请公布号 US2005014731(A1) 申请公布日期 2005.01.20
申请号 US20040855944 申请日期 2004.05.28
申请人 SOLVAY PHARMACEUTICALS GMBH 发明人 ALT JEANNETTE;EISELE BERND
分类号 A61K31/00;A61K31/567;A61K31/569;A61K31/57;A61K31/575;A61K31/585;A61P3/10;A61P9/00;A61P17/02;A61P17/06;A61P19/02;A61P25/28;A61P31/04;A61P31/08;A61P31/12;A61P31/18;A61P37/00;A61P37/02;A61P37/06;(IPC1-7):A61K31/56 主分类号 A61K31/00
代理机构 代理人
主权项
地址